2024 Over the Counter flex card FAQ
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1321 - 1330 ntawm 3685
Tus kws kho mob
P69-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 02, 2023
Tus kws kho mob
P70-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective December 4, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 02, 2023
Tus kws kho mob
P71-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 02, 2023
Tus kws kho mob
QP80-23 Blue Cross Response to Medical Oncology Drug Shortage of Cisplatin and Carboplatin
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP81-23 Update: Medical Drug Update for Tofersen (Qalsody), Delandistrogene Moxeparvovec (Elevidys), and Donislecel (Lantidra)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP82-23 Commercial Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Izervay™, and Veopoz™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Tus kws kho mob
QP84-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2023
Daim Ntawv Yuav Tshuaj thiab Chaw Muag Tshuaj
Tus kws kho mob
policyii-174-med-drug-eval-process-list-2023-1001.pdf